Cheong Chee Mei, Golder Allan M, Horgan Paul G, Roxburgh Campbell S D, McMillan Donald C
Academic Unit of Surgery, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom.
Oncol Lett. 2022 Jul 5;24(3):296. doi: 10.3892/ol.2022.13416. eCollection 2022 Sep.
Surgical site infections remain a significant cause of morbidity following colon cancer surgery. Although diabetes has been recognised as a risk factor, patients with asymptomatic diabetes are likely underdiagnosed. The aim of the present study was to determine the relationship between preoperative glycated haemoglobin (HbA1C), clinicopathological characteristics and the influence on surgical site infection in a cohort of patients undergoing potentially curative colon cancer surgery. Patients who underwent elective, potentially curative colon cancer surgery between January 2011 and December 2014 were assessed for HbA1C levels (mmol/mol) measured within 3 months preoperatively. Clinicopathological data were recorded in a maintained database. A multivariate binary logistic regression model was used to assess the relationship between HbA1C, clinicopathological characteristics and surgical site infections. A total of 362 patients had HbA1C levels preoperatively recorded. HbA1C was significantly associated with body mass index (BMI), diabetes, smoking status, visceral fat area and skeletal muscle index. As determined by multivariate analysis, preoperative HbA1C levels remained independently associated with an increased risk of surgical site infections (OR 1.69, 95% CI 1.05-2.7; P=0.031) together with BMI (OR 1.91, 95% CI 1.36-2.67; P<0.001). Notably, in the present study, tumour-based factors, such as tumour location and TNM status, were not associated with infective complications. By contrast, host factors, such as BMI and pre-operative HbA1C were associated with surgical site infections suggesting that these factors were of more importance in determining short-term outcomes. In conclusion, objective measurements of BMI and HbA1C effectively stratified the risk of developing surgical site infection from 8 to 59%; therefore, HbA1C levels should be determined to allow for preoperative optimisation.
手术部位感染仍然是结肠癌手术后发病的一个重要原因。尽管糖尿病已被确认为一个风险因素,但无症状糖尿病患者可能未得到充分诊断。本研究的目的是确定术前糖化血红蛋白(HbA1C)、临床病理特征之间的关系,以及它们对一组接受潜在根治性结肠癌手术患者手术部位感染的影响。对2011年1月至2014年12月期间接受择期、潜在根治性结肠癌手术的患者术前3个月内测量的HbA1C水平(mmol/mol)进行评估。临床病理数据记录在一个维护的数据库中。采用多变量二元逻辑回归模型评估HbA1C、临床病理特征与手术部位感染之间的关系。共有362例患者术前记录了HbA1C水平。HbA1C与体重指数(BMI)、糖尿病、吸烟状况、内脏脂肪面积和骨骼肌指数显著相关。多变量分析确定,术前HbA1C水平与手术部位感染风险增加独立相关(比值比1.69,95%置信区间1.05 - 2.7;P = 0.031),BMI也是如此(比值比1.91,95%置信区间1.36 - 2.67;P < 0.001)。值得注意的是,在本研究中,基于肿瘤的因素,如肿瘤位置和TNM分期,与感染性并发症无关。相比之下,宿主因素,如BMI和术前HbA1C与手术部位感染相关,这表明这些因素在决定短期预后方面更为重要。总之,BMI和HbA1C的客观测量有效地将手术部位感染风险从8%分层至59%;因此,应测定HbA1C水平以便进行术前优化。